SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NTEG- Bloodless Glucose Monitor
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Lovejoy who wrote (56)10/5/1997 6:37:00 PM
From: William T. Katz   of 176
 
Thanks for the note Jim. I agree that a less invasive and easier glucose monitoring system should help compliance ... and that is really the whole key to treating diabetes. More samples are better particularly if a person is changing activity levels and feedings. So from that perspective, I wonder if clinicians would allow less accurate systems if the cost and outcomes are better than the current methods. After all, that is really what it's all about. Will the systems make an impact on the clinical outcomes when everything (accuracy, cost, ease of use, invasiveness of insulin tx) is factored in? But of course, we won't really know that until these systems start being used in large numbers and under a large range of environments.

Regards,
Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News